Gene regulation by RNA binding proteins and microRNAs in angiogenesis

Trends in Molecular Medicine

Volumn 17, Issue 11, 2011, Pages 650-658

  Chang, Sung Hee ^a   Hla, Timothy ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; RNA BINDING PROTEIN; RNA POLYMERASE II; VASCULOTROPIN;

3' UNTRANSLATED REGION; ANGIOGENESIS; BIOGENESIS; ENDOTHELIAL PROGENITOR CELL; GENE CONTROL; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HYPOXIA; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN RNA BINDING; REVIEW; RNA SPLICING; RNA STABILITY; RNA TRANSCRIPTION; SERUM; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD VESSELS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; RNA-BINDING PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80755128123     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2011.06.008     Document Type: Review

References (80)

1. Fraisl P., et al. Regulation of angiogenesis by oxygen and metabolism. Dev. Cell 2009, 16:167-179.
2. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 2007, 8:464-478.
3. Ding B.S., et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 2010, 468:310-315.
4. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 2003, 9:702-712.
5. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 2003, 9:653-660.
6. Kerbel R.S. Tumor angiogenesis. N. Engl. J. Med. 2008, 358:2039-2049.
7. Flamme I., et al. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell Physiol. 1997, 173:206-210.
8. De Val S., Black B.L. Transcriptional control of endothelial cell development. Dev. Cell 2009, 16:180-195.
9. Jain R.K. Molecular regulation of vessel maturation. Nat. Med. 2003, 9:685-693.
10. Mammoto A., et al. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 2009, 457:1103-1108.
11. Lyden D., et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999, 401:670-677.
12. Keene J.D. RNA regulons: coordination of post-transcriptional events. Nat. Rev. Genet. 2007, 8:533-543.
13. Lukong K.E., et al. RNA-binding proteins in human genetic disease. Trends Genet. 2008, 24:416-425.
14. Nicoli S., et al. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 2010, 464:1196-1200.
15. Wang S., Olson E.N. AngiomiRs - key regulators of angiogenesis. Curr. Opin. Genet. Dev. 2009, 19:205-211.
16. Poliseno L., et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465:1033-1038.
17. Eiring A.M., et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 2010, 140:652-665.
18. Ebralidze A.K., et al. PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element. Genes Dev. 2008, 22:2085-2092.
19. Farina K.L., et al. Two ZBP1 KH domains facilitate beta-actin mRNA localization, granule formation, and cytoskeletal attachment. J. Cell Biol. 2003, 160:77-87.
20. Krol J., et al. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
21. Siomi H., Siomi M.C. Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell 2010, 38:323-332.
22. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
23. Filipowicz W., et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
24. Guo H., et al. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
25. Selbach M., et al. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
26. Vasudevan S., et al. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
27. Agami R. microRNAs, RNA binding proteins and cancer. Eur. J. Clin. Invest. 2010, 40:370-374.
28. Kedde M., Agami R. Interplay between microRNAs and RNA-binding proteins determines developmental processes. Cell Cycle 2008, 7:899-903.
29. Shaw G., Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986, 46:659-667.
30. von Roretz C., Gallouzi I.E. Decoding ARE-mediated decay: is microRNA part of the equation?. J. Cell Biol. 2008, 181:189-194.
31. Masuda K., et al. RNA-binding proteins implicated in the hypoxic response. J. Cell Mol. Med. 2009, 13:2759-2769.
32. Essafi-Benkhadir K., et al. Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation. Mol. Biol. Cell 2007, 18:4648-4658.
33. Lafarga V., et al. p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint. Mol. Cell Biol. 2009, 29:4341-4351.
34. Jacobsen A., et al. Signatures of RNA binding proteins globally coupled to effective microRNA target sites. Genome Res. 2010, 20:1010-1019.
35. Bhattacharyya S.N., et al. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125:1111-1124.
36. Jing Q., et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005, 120:623-634.
37. Kim H.H., et al. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev. 2009, 23:1743-1748.
38. Jafarifar F., et al. Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J. 2011, 30:1324-1334.
39. Trabucchi M., et al. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009, 459:1010-1014.
40. Viswanathan S.R., et al. Selective blockade of microRNA processing by Lin28. Science 2008, 320:97-100.
41. Viswanathan S.R., Daley G.Q. Lin28: a microRNA regulator with a macro role. Cell 2010, 140:445-449.
42. Viswanathan S.R., et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 2009, 41:843-848.
43. Bernstein E., et al. Dicer is essential for mouse development. Nat. Genet. 2003, 35:215-217.
44. Yang W.J., et al. Dicer is required for embryonic angiogenesis during mouse development. J. Biol. Chem. 2005, 280:9330-9335.
45. Suarez Y., et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14082-14087.
46. Kuehbacher A., et al. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 2007, 101:59-68.
47. Chen Y., Gorski D.H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008, 111:1217-1226.
48. Harris T.A., et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1516-1521.
49. Poliseno L., et al. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006, 108:3068-3071.
50. Fasanaro P., et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 2008, 283:15878-15883.
51. Fish J.E., et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 2008, 15:272-284.
52. Wang S., et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 2008, 15:261-271.
53. Wurdinger T., et al. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008, 14:382-393.
54. Bonauer A., et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324:1710-1713.
55. Dews M., et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 2006, 38:1060-1065.
56. Anand S., et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 2010, 16:909-914.
57. Ivey K.N., et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2008, 2:219-229.
58. He L., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833.
59. Lee D.Y., et al. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:20350-20355.
60. Hua Z., et al. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE 2006, 1:e116.
61. Levy A.P. Hypoxic regulation of VEGF mRNA stability by RNA-binding proteins. Trends Cardiovasc. Med. 1998, 8:246-250.
62. Levy N.S., et al. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 1998, 273:6417-6423.
63. Suswam E., et al. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells. Cancer Res. 2008, 68:674-682.
64. Ciais D., et al. Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b. Oncogene 2004, 23:8673-8680.
65. Ray P.S., et al. A stress-responsive RNA switch regulates VEGFA expression. Nature 2009, 457:915-919.
66. Bell S.E., et al. The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. Dev. Dyn. 2006, 235:3144-3155.
67. Stumpo D.J., et al. Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis. Blood 2009, 114:2401-2410.
68. Lu J.Y., et al. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes Dev. 2006, 20:3174-3184.
69. Taylor G.A., et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 1996, 4:445-454.
70. Katsanou V., et al. The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development. Mol. Cell. Biol. 2009, 29:2762-2776.
71. Ghosh M., et al. Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. J. Clin. Invest. 2009, 119:3530-3543.
72. Papadaki O., et al. Control of thymic T cell maturation, deletion and egress by the RNA-binding protein HuR. J. Immunol. 2009, 182:6779-6788.
73. Valadi H., et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
74. Skog J., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10:1470-1476.
75. David C.J., et al. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 2010, 463:364-368.
76. Ladomery M.R., et al. Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm. Cancer Lett. 2007, 249:133-142.
77. Kalsotra A., et al. MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development. Genes Dev. 2010, 24:653-658.
78. Campochiaro P.A. Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders. Gene Ther. 2006, 13:559-562.
79. Asirvatham A.J., et al. MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Mol. Immunol. 2008, 45:1995-2006.
80. Hodson D.J., et al. Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat. Immunol. 2010, 11:717-724.